Showing results (1631-1640 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|October 8, 2003
Genetics and the management of women at high risk for breast cancerBetty A Mincey
The Oncologist|December 6, 2003
Velcade: U.S. FDA approval for the treatment of multiple myeloma progressing on prior therapyRobert C Kane, Peter F Bross, Ann T Farrell, et al.
The Oncologist|May 8, 2013
Unmet needs in the prediction and detection of metastases in prostate cancerOliver Sartor, Mario Eisenberger, Michael W Kattan, et al.
The Oncologist|April 13, 2013
A phase II randomized dose escalation trial of sorafenib in patients with advanced hepatocellular carcinomaLorenza Rimassa, Tiziana Pressiani, Corrado Boni, et al.
The Oncologist|May 28, 2013
Ipilimumab, vemurafenib, dabrafenib, and trametinib: synergistic competitors in the clinical management of BRAF mutant malignant melanomaJason J Luke, F Stephen Hodi
The Oncologist|July 16, 2013
Genomic alterations in advanced esophageal cancer may lead to subtype-specific therapiesPatrick M Forde, Ronan J Kelly
The Oncologist|July 2, 2013
Novel targets in non-small cell lung cancer: ROS1 and RET fusionsJustin F Gainor, Alice T Shaw
The Oncologist|January 30, 2013
Analysis of regional timelines to set up a global phase III clinical trial in breast cancer: the adjuvant lapatinib and/or trastuzumab treatment optimization experienceOtto Metzger-Filho, Evandro de Azambuja, Ian Bradbury, et al.
The Oncologist|January 10, 2013
CF102 for the treatment of hepatocellular carcinoma: a phase I/II, open-label, dose-escalation studySalomon M Stemmer, Ofer Benjaminov, Gal Medalia, et al.
The Oncologist|January 10, 2013
Relative effectiveness and safety of chemotherapy in elderly and nonelderly patients with stage III colon cancer: a systematic reviewAnna Hung, C Daniel Mullins
Pageof 571